Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Intellectual Property

Intellectual Property

3 Months Ended

Nov. 30, 2021

Intellectual Property

9. Intellectual Property

9.	Intellectual Property

The following is a list of US capitalized patents held by the Company:

Issued Patent #	Patent Certificate Grant Date	Patent Family
US 9,474,725 B1	10/25/2016	Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof
US 9,839,612 B2	12/12/2017
US 9,972,680 B2	05/15/2018
US 9,974,739 B2	05/22/2018
US 10,084,044 B2	09/25/2018
US 10,103,225 B2	10/16/2018
US 10,381,440	08/13/2019
US 10,374,036	08/06/2019
US 10,756,180	08/25/2020

A continuity schedule for capitalized patents is presented below:

		November 31,				August 31,
		2021
		$				$
Balance – beginning			364,623				292,000
Addition			15,840				79,493
Amortization			(1,717	)			(6,870	)
Balance – ending			378,746				364,623
Patents are amortized over their 20 year legal life.